ITeos Therapeutics Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow JonesDec 13 06:37 ET · Ratings

H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $21

Moomoo NewsDec 13 06:31 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on ITeos Therapeutics, Maintains $21 Price Target

BenzingaDec 13 06:27 ET

Strategic Focus on Belrestotug Drives Buy Rating for ITeos Therapeutics With Adjusted Price Target of $21

TipRanksDec 13 06:15 ET · Ratings

Express News | Iteos Therapeutics Inc : Piper Sandler Cuts Target Price to $16 From $36

ReutersDec 13 02:14 ET

ITeos Therapeutics Says Deprioritizing Cancer Drug Candidate Inupadenant

MT NewswiresDec 12 09:35 ET